Myc lacks E2F1's ability to suppress skin carcinogenesis.
about
Stathmin is dispensable for tumor onset in miceDeciphering the role of nuclear and cytoplasmic IKKα in skin cancerIdentification of a Novel Proto-oncogenic Network in Head and Neck Squamous Cell CarcinomaE2F2 suppresses Myc-induced proliferation and tumorigenesis.Cdk2 deficiency decreases ras/CDK4-dependent malignant progression, but not myc-induced tumorigenesisATM promotes apoptosis and suppresses tumorigenesis in response to Myc.ARF differentially modulates apoptosis induced by E2F1 and Myc.Skin epidermis lacking the c-Myc gene is resistant to Ras-driven tumorigenesis but can reacquire sensitivity upon additional loss of the p21Cip1 gene.Skp2 is necessary for Myc-induced keratinocyte proliferation but dispensable for Myc oncogenic activity in the oral epitheliumMyc, Aurora Kinase A, and mutant p53(R172H) co-operate in a mouse model of metastatic skin carcinoma.MYC in mammalian epidermis: how can an oncogene stimulate differentiation?Regulation of tissue- and stimulus-specific cell fate decisions by p53 in vivo.c-Myc induction of programmed cell death may contribute to carcinogenesis: a perspective inspired by several concepts of chemical carcinogenesis.Modeling cutaneous squamous carcinoma development in the mouseLack of cyclin-dependent kinase 4 inhibits c-myc tumorigenic activities in epithelial tissues.Cyclin D3 deficiency inhibits skin tumor development, but does not affect normal keratinocyte proliferation.C/EBPalpha and beta couple interfollicular keratinocyte proliferation arrest to commitment and terminal differentiation.Opposing functions of Fbxw7 in keratinocyte growth, differentiation and skin tumorigenesis mediated through negative regulation of c-Myc and Notch.
P2860
Q21134036-D2BDF469-D4D7-4FF0-8DDC-A0156F16225BQ28828173-88840E4E-C577-4CD4-B3F0-68111BB2D164Q28834533-18938365-6118-4CE5-91EF-23B2B9B75FEFQ33618472-66C7BC64-798E-46C7-8EBC-AF7FE2A40495Q33810358-CAD7C5D3-E565-46EA-8040-D02CFB5D3E6FQ34298505-6186311B-0FD4-478F-A61D-F47D54ADAD3AQ34302211-77D29385-D445-428D-8270-FCF8CBD74308Q34958801-FA724C93-B222-412C-8DA8-281F3CCFF424Q35070668-B5FE5CAE-3974-4A07-8AAD-62E95D8948C8Q36078222-D20E6CC6-253A-4839-AA22-2B66B7D4F082Q37091735-EBB42897-E02B-41CC-B70D-E660B00211CFQ37801346-90ED0C18-0760-43C0-AC63-1311CA183900Q37833424-AC86C908-DEFD-4EFD-92A1-2F909B8E05A3Q38245726-4E27CCEA-7CFC-45EF-BC63-F7135928FB39Q39757012-E33AC193-5806-4A3D-8F20-218FB48BFF01Q41614081-1C4BE2F8-D402-43A1-BD98-F2165ADD7421Q42459766-B7559DEC-3D52-4A38-8322-F9EA09573D57Q46223004-0FFBC019-404D-4E98-BA4F-F1B0658D471B
P2860
Myc lacks E2F1's ability to suppress skin carcinogenesis.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Myc lacks E2F1's ability to suppress skin carcinogenesis.
@en
Myc lacks E2F1's ability to suppress skin carcinogenesis.
@nl
type
label
Myc lacks E2F1's ability to suppress skin carcinogenesis.
@en
Myc lacks E2F1's ability to suppress skin carcinogenesis.
@nl
prefLabel
Myc lacks E2F1's ability to suppress skin carcinogenesis.
@en
Myc lacks E2F1's ability to suppress skin carcinogenesis.
@nl
P2093
P2860
P356
P1433
P1476
Myc lacks E2F1's ability to suppress skin carcinogenesis.
@en
P2093
Johnson DG
Rounbehler RJ
Schneider-Broussard R
P2860
P2888
P304
P356
10.1038/SJ.ONC.1204691
P407
P577
2001-08-01T00:00:00Z
P5875
P6179
1052548298